Nanobiotix Net Income 2024

Nanobiotix Net Income

-35.29 M EUR

Nanobiotix Dividend yield

Ticker

NANO.PA

ISIN

FR0011341205

WKN

A1J7EB

In 2024, Nanobiotix's profit amounted to -35.29 M EUR, a -11.12% increase from the -39.7 M EUR profit recorded in the previous year.

The Nanobiotix Net Income history

YEARNET INCOME (undefined EUR)
2029e69.08
2028e34.3
2027e-30.49
2026e-32.92
2025e-49.25
2024e-35.29
2023-39.7
2022-57.04
2021-47
2020-33.59
2019-50.92
2018-30.35
2017-26.14
2016-21.88
2015-17
2014-9.56
2013-8.14
2012-5.33
2011-5.25
2010-4.09
2009-1.51

Nanobiotix Aktienanalyse

What does Nanobiotix do?

Nanobiotix SA is a biotechnology company specializing in the development of nanoparticles used in cancer therapy to increase the effectiveness of radiation therapy. It was founded in 2003 in Paris, France by Dr. Laurent Lévy and his team. The company went public in 2012 and is currently listed on the Euronext Paris exchange. Nanobiotix's business model is based on the production and marketing of nanoparticles called NBTXR3, which enhance the effectiveness of radiation therapy. The company works with various partners to further develop its technology and explore new applications. Nanobiotix has two main divisions: one focused on developing nanoparticles to enhance radiation therapy for cancer, and another dedicated to using nanoparticles as drug carriers. Its flagship product, NBTXR3, is designed specifically for cancer therapy and has shown promising results. Nanobiotix is also working on combining NBTXR3 with immunotherapies to further improve cancer treatment. In summary, Nanobiotix is an innovative company specializing in the development of nanoparticles to enhance radiation therapy for cancer and improve patient treatment. Nanobiotix ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Net Income Details

Understanding Nanobiotix's Profit Margins

The profit margins of Nanobiotix represent the net income earned after deducting all operational expenses, costs, and taxes from the revenue. This figure is a clear indicator of Nanobiotix's financial health, operational efficiency, and profitability. Higher profit margins signify better cost management and income generation capabilities.

Year-to-Year Comparison

Evaluating Nanobiotix's profit on a yearly basis can offer significant insights into its financial growth, stability, and trends. A consistent increase in profit suggests improved operational efficiency, cost management, or increased revenue, while a decrease may indicate rising costs, declining sales, or operational challenges.

Impact on Investments

Nanobiotix's profit figures are critical for investors who are aiming to understand the company's financial standing and future growth prospects. Increased profits often lead to higher stock valuations, boosting investor confidence and attracting more investments.

Interpreting Profit Fluctuations

When Nanobiotix’s profit increases, it often indicates enhanced operational efficiency or increased sales. In contrast, a decline in profit can signal operational inefficiencies, increased costs, or competitive pressures, necessitating strategic interventions to boost profitability.

Frequently Asked Questions about Nanobiotix Stock

How much profit has Nanobiotix made this year?

Nanobiotix has made -35.29 M EUR this year.

How has the profit developed compared to last year?

The profit has increased by -11.12% compared to last year fallen

What impact do the earnings have on the shareholders?

An increase in earnings is usually seen as a positive indicator for shareholders as it means that the company is generating profits.

How does Nanobiotix publish its earnings?

Nanobiotix publishes its earnings in the form of quarterly or annual reports.

Which financial indicators are included in the quarterly or annual reports?

The quarterly or annual reports contain information about sales and profit, cash flow, balance sheet, and other fundamentals.

Why is it important for investors to know the earnings of Nanobiotix?

The profits of Nanobiotix are an important indicator of the financial health of the company and can help investors decide whether they want to invest in the company or not.

How can one learn more about the earnings of Nanobiotix?

You can learn more about the earnings of Nanobiotix by reviewing the quarterly or annual reports or following the company presentations.

How much dividend does Nanobiotix pay?

Over the past 12 months, Nanobiotix paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Nanobiotix is expected to pay a dividend of 0 EUR.

What is the dividend yield of Nanobiotix?

The current dividend yield of Nanobiotix is .

When does Nanobiotix pay dividends?

Nanobiotix pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Nanobiotix?

Nanobiotix paid dividends every year for the past 0 years.

What is the dividend of Nanobiotix?

For the upcoming 12 months, dividends amounting to 0 EUR are expected. This corresponds to a dividend yield of 0 %.

In which sector is Nanobiotix located?

Nanobiotix is assigned to the 'Health' sector.

Wann musste ich die Aktien von Nanobiotix kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Nanobiotix from 5/25/2024 amounting to 0 EUR, you needed to have the stock in your portfolio before the ex-date on 5/25/2024.

When did Nanobiotix pay the last dividend?

The last dividend was paid out on 5/25/2024.

What was the dividend of Nanobiotix in the year 2023?

In the year 2023, Nanobiotix distributed 0 EUR as dividends.

In which currency does Nanobiotix pay out the dividend?

The dividends of Nanobiotix are distributed in EUR.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

The Nanobiotix stock can be added to a savings plan with the following providers: Trade Republic

Andere Kennzahlen von Nanobiotix

Our stock analysis for Nanobiotix Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Nanobiotix Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.